- Y Diweddaraf sydd Ar Gael (Diwygiedig)
- Gwreiddiol (a wnaed Fel)
Dyma’r fersiwn wreiddiol (fel y’i gwnaed yn wreiddiol). This item of legislation is currently only available in its original format.
3. In the table in Schedule 3A to the principal Order(1) (substances which may be prescribed, administered or directed for administration by extended formulary nurse prescribers and conditions for such prescription or administration)—
(a)for the entry for “Erythromycin”, in column 2, after “External Use” insert “or oral”;
(b)for the entry “Fusidic acid”, in column 2 for “Opthalmic Use” substitute “External Use”;
(c)for the entry “Hycosine butylbromide”, in column 2, after “parenteral” insert “or transdermal”;
(d)for the entry “Hycosine hydrobromide”, in column 2, for “Oral, parenteral or transdermal administration in palliative care” substitute “Oral or parenteral administration in palliative care”;
(e)for the entry “Metronidazole”, in column 2 for “External use or oral” substitute “External use, oral or rectal”;
(f)for the entry “Prednisolone sodium phosphate”, in column 2, after “Aural” insert “or oral”;
(g)in column 1 insert, at the appropriate place in the alphabetical order of the entries as they appear in that column, each of the entries set out in column 1 below, and in column 2 insert, against those entries, the corresponding entries in column 2 below—
Column 1 | Column 2 |
---|---|
Amitriptyline hydrochloride | Oral |
Azithromycin dihydrate | Oral |
Carbamazepine | Oral or rectal |
Clavulanic acid | Oral |
Conjugated oestrogens (equine) | External use |
Diclofenac potassium | Oral |
Diclofenac sodium | Oral or rectal |
Erythromycin ethyl succinate | Oral |
Erythromycin stearate | Oral |
Estradiol | External use |
Estriol | External use |
Etonogestrel | Implant |
Flumazenil | Parenteral |
Gabapentin | Oral |
Glucagon hydrochloride | Parenteral |
Glucose | Parenteral |
Imipramine hydrochloride | Oral |
Lignocaine hydrochloride | External use or parenteral |
Lymecycline | Oral |
Nortriptyline hydrochloride | Oral |
Prednisolone | Oral |
Salbutamol sulphate | Inhalation |
Sodium fusidate | External use |
Terbutaline sulphate | Inhalation |
Schedule 3A was inserted by SI 2002/549, and amended by SI 2003/696 and 2915.
Y Diweddaraf sydd Ar Gael (diwygiedig):Y fersiwn ddiweddaraf sydd ar gael o’r ddeddfwriaeth yn cynnwys newidiadau a wnaed gan ddeddfwriaeth ddilynol ac wedi eu gweithredu gan ein tîm golygyddol. Gellir gweld y newidiadau nad ydym wedi eu gweithredu i’r testun eto yn yr ardal ‘Newidiadau i Ddeddfwriaeth’.
Gwreiddiol (Fel y’i Deddfwyd neu y’i Gwnaed): Mae'r wreiddiol fersiwn y ddeddfwriaeth fel ag yr oedd pan gafodd ei deddfu neu eu gwneud. Ni wnaed unrhyw newidiadau i’r testun.
Gallwch wneud defnydd o ddogfennau atodol hanfodol a gwybodaeth ar gyfer yr eitem ddeddfwriaeth o’r tab hwn. Yn ddibynnol ar yr eitem ddeddfwriaeth sydd i’w gweld, gallai hyn gynnwys:
Defnyddiwch y ddewislen hon i agor dogfennau hanfodol sy’n cyd-fynd â’r ddeddfwriaeth a gwybodaeth am yr eitem hon o ddeddfwriaeth. Gan ddibynnu ar yr eitem o ddeddfwriaeth sy’n cael ei gweld gall hyn gynnwys:
liciwch ‘Gweld Mwy’ neu ddewis ‘Rhagor o Adnoddau’ am wybodaeth ychwanegol gan gynnwys